The impact of SARS-CoV-2 on the cystic fibrosis foundation therapeutics development network.
The impact of SARS-CoV-2 on the cystic fibrosis foundation therapeutics development network.
复制标题
DOI:
10.1016/j.jcf.2020.12.007
复制
发表时间:
2021-03
期刊:
影响因子:
--
通讯作者:
Nichols DP
中科院分区:
文献类型:
--
作者:
Pearson K;Mayer-Hamblett N;Goss CH;Retsch-Bogart GZ;VanDalfsen JM;Burks P;Rosenbluth D;Clancy JP;Hoffman A;Nichols DP
The Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV-2) global pandemic significantly impacted CF clinical research within the Cystic Fibrosis Foundation Therapeutics Development Network (CFF TDN). A Research Electronic Data Capture (REDCap) survey was developed and sent to network sites to monitor and understand the impact on research teams, ongoing and anticipated clinical research, and specific clinical and research procedures. Key findings indicated an early impact on participant enrollment, research team stability, and procedures such as spirometry and sputum induction. These trends steadily improved over the months as research activities began to recover across the TDN. While SARS-CoV-2 created a significant challenge it also highlights new opportunities to expand CF research with greater focus on data collection outside of research centers and increased access for remote participation.
DOI:
10.1016/j.jcf.2020.10.003
发表时间:
2020-11
期刊:
Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society
影响因子:
--
作者:
McClenaghan E;Cosgriff R;Brownlee K;Ahern S;Burgel PR;Byrnes CA;Colombo C;Corvol H;Cheng SY;Daneau G;Elbert A;Faro A;Goss CH;Gulmans V;Gutierrez H;de Monestrol I;Jung A;Justus LN;Kashirskaya N;Marshall BC;McKone E;Middleton PG;Mondejar-Lopez P;Pastor-Vivero MD;Padoan R;Rizvi S;Ruseckaite R;Salvatore M;Stephenson AL;Filho LVRDS;Melo J;Zampoli M;Carr SB;Global Registry Harmonization Group
通讯作者:
Global Registry Harmonization Group
影响因子:
5.2
作者:
Cosgriff, Rebecca;Ahern, Susannah;Carr, Siobhan B.
通讯作者:
Carr, Siobhan B.